Market Research Logo

Australia Pharmaceuticals & Healthcare Q4 2018

Australia Pharmaceuticals & Healthcare Q4 2018

Key View:

Cost containment pressures will continue to present headwinds to multinational pharmaceutical companies seeking tolist their products on the Australian Pharmaceutical Benefits Scheme. Nonetheless, Australia will remain one of the most attractivemarkets globally for innovative drugmakers due to the strength of its regulatory environment, the population's wealth and positivedemographic trends.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Innovative Pharmaceuticals & Healthcare Risk/Reward Index
Australia Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Australian Pharmaceutical Industries
CSL
GlaxoSmithKline
Mayne Pharma Group
Sanofi
Sigma
Australia Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report